November / December
PRODUCTS | back to list
KODAK AND NSI LAUNCH VERSATILE DOCUMENT IMAGING SOLUTION TO HELP USERS QUICKLY CAPTURE, SHARE AND ELECTRONICALLY FILE INFORMATION
Coherex Medical, Inc. has successfully completed the first human cases of its Co-herex FlatStent PFO Closure System. Under the direction of Professor Horst Sievert, M.D., an internationally renowned interventional cardiologist and principal investigator for the COHEREX-EU Study, Coherex successfully conducted procedures in Frankfurt, Germany to close the common heart defect known as a Patent Foramen Ovale (PFO). “ e Coherex FlatStent PFO Closure System worked flawlessly during each of our procedures, just as we expected,” Dr. Sievert said. “ e device was extremely easy to use and there have been no complications from its use in any of the cases. The Coherex FlatStent marks the beginning of a new era of medical device technology and significantly raises the bar by providing a simple and safe alternative in PFO closure for physicians and their patients.” “These fantastic results are the product of many years of research and hard work by Coherex’ employees,” said Richard J. Linder, Coherex president and CEO. “Our assertion that the Coherex FlatStent is a new breed of stent to treat heart defects has now been successfully validated in patients and confirms the confidence our investors have had in our vision. We look forward to additional clinical research in Europe as part of the COHEREX-EU Study.. These initial procedures were performed at Sankt Katharinen Hospital in Frankfurt as part of the company’s COHEREX-EU study. Coherex expects to include data from these cases in its application for CE Mark clearance.
Coherex Medical, Inc.
RRC #6091
RRC #6091
